Search Results - Merck,

Refine Results
  1. 1

    Merck Lifts Guidance on Life Science, Electronics.

    Authors: Wind, Sonja (AUTHOR)

    Source: Bloomberg.com. 8/6/2026, pN.PAG-N.PAG. 1p.

    HTML Full Text
    Save to List
  2. 2

    Merck Lifts 2026 Sales Forecast on Strength of Newer Drugs.

    Authors: Muller, Madison (AUTHOR)

    Source: Bloomberg.com. 8/4/2026, pN.PAG-N.PAG. 1p.

    HTML Full Text
    Save to List
  3. 3

    Merck to Settle Bulk of Gardasil Suits for About $50 Million.

    Authors: Feeley, Jef (AUTHOR)

    Source: Bloomberg.com. 6/4/2026, pN.PAG-N.PAG. 1p.

    HTML Full Text
    Save to List
  4. 4

    Merck to Settle Bulk of Gardasil Lawsuits for Around $50 Million.

    Authors: Feeley, Jef (AUTHOR)

    Source: Bloomberg.com. 6/4/2026, pN.PAG-N.PAG. 1p.

    HTML Full Text
    Save to List
  5. 5

    Merck's Gardasil Vaccine in RFK Jr.'s Sights Faces Court Clash.

    Authors: Feeley, Jef (AUTHOR)

    Source: Bloomberg.com. 5/8/2026, pN.PAG-N.PAG. 1p.

    HTML Full Text
    Save to List
  6. 6

    Merck KGaA Agrees on $11.3 Billion Purchase of Bio-Techne.

    Authors: Wind, Sonja (AUTHOR)

    Source: Bloomberg.com. 6/25/2026, pN.PAG-N.PAG. 1p.

    HTML Full Text
    Save to List
  7. 7

    Merck's Forecast Misses Expectations on Gardasil Woes.

    Authors: Muller, Madison Thornton, Miquéla V

    Source: Bloomberg.com. 2/3/2026, pN.PAG-N.PAG. 1p.

    HTML Full Text
    Save to List
  8. 8

    MarketLine Company Profile: Merck & Co., Inc.

    Source: Merck & Co., Inc. MarketLine Company Profile. 5/15/2026, p1-90. 90p.

    HTML Full Text PDF Full Text
    Save to List
  9. 9

    Merck Eyes $6 Billion in Seven-Part Bond Sale for Terns Deal.

    Authors: Mutua, Caleb Gambale, Michael

    Source: Bloomberg.com. 5/18/2026, pN.PAG-N.PAG. 1p.

    HTML Full Text
    Save to List
  10. 10

    Merck Beats Sales Estimates Amid Demand for Newer Drugs.

    Authors: Muller, Madison (AUTHOR)

    Source: Bloomberg.com. 4/30/2026, pN.PAG-N.PAG. 1p.

    HTML Full Text
    Save to List
  11. 11

    Merck & Co., Inc. SWOT Analysis.

    Source: Merck & Co., Inc. SWOT Analysis. 5/15/2026, p1-7. 7p.

    PDF Full Text
    Save to List
  12. 12

    MarketLine Company Profile: Merck KGaA.

    Source: Merck KGaA MarketLine Company Profile. 5/15/2026, p1-76. 76p.

    HTML Full Text PDF Full Text
    Save to List
  13. 13

    Ebola Response Turns to Merck Vaccine, Gilead Drug as Congo Outbreak Worsens.

    Authors: Kew, Janice Gale, Jason

    Source: Bloomberg.com. 8/7/2026, pN.PAG-N.PAG. 1p.

    HTML Full Text
    Save to List
  14. 14

    Merck KGaA to Buy US Company Bio-Techne for $11.3 Billion.

    Authors: Wind, Sonja (AUTHOR)

    Source: Bloomberg.com. 6/25/2026, pN.PAG-N.PAG. 1p.

    HTML Full Text
    Save to List
  15. 15

    Merck KGaA Predicts Slightly Better Profit as New CEO Takes Over.

    Authors: Wind, Sonja (AUTHOR)

    Source: Bloomberg.com. 5/13/2026, pN.PAG-N.PAG. 1p.

    HTML Full Text
    Save to List
  16. 16

    Merck to Acquire Terns Pharmaceuticals in $6.7 Billion Deal.

    Authors: Muller, Madison Davis, Michelle F.

    Source: Bloomberg.com. 3/25/2026, pN.PAG-N.PAG. 1p.

    HTML Full Text
    Save to List
  17. 17

    Scientists Seek to Repurpose Existing Merck Ebola Vaccine.

    Authors: Kew, Janice Gale, Jason

    Source: Bloomberg.com. 7/31/2026, pN.PAG-N.PAG. 1p.

    HTML Full Text
    Save to List
  18. 18

    Merck to Create a Separate Cancer Unit as Patent Cliff Looms.

    Authors: Muller, Madison Connelly, Frank

    Source: Bloomberg.com. 2/23/2026, pN.PAG-N.PAG. 1p.

    HTML Full Text
    Save to List
  19. 19

    Merck to Create a Separate Cancer Unit as Patent Cliff Looms.

    Authors: Connelly, Frank (AUTHOR)

    Source: Bloomberg.com. 2/23/2026, pN.PAG-N.PAG. 1p.

    HTML Full Text
    Save to List
  20. 20

    Merck KGaA SWOT Analysis.

    Source: Merck KGaA SWOT Analysis. 5/15/2026, p1-7. 7p.

    PDF Full Text
    Save to List

Search Tools: